This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
rsi: Archive
After Plunging -11.42% in 4 Weeks, Here's Why the Trend Might Reverse for Global Medical REIT (GMRE)
by Zacks Equity Research
Global Medical REIT (GMRE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
GMRENo Net Change
rsi stock-price-movement
After Plunging -19.71% in 4 Weeks, Here's Why the Trend Might Reverse for Zscaler (ZS)
by Zacks Equity Research
Zscaler (ZS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ZSNegative Net Change
rsi stock-price-movement
Down -28.22% in 4 Weeks, Here's Why You Should You Buy the Dip in Gevo (GEVO)
by Zacks Equity Research
Gevo (GEVO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
GEVOPositive Net Change
rsi stock-price-movement
Iridium (IRDM) Loses -9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Iridium (IRDM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
IRDMNegative Net Change
rsi stock-price-movement
Adicet Bio (ACET) Loses -16.39% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Adicet Bio (ACET) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ACETNegative Net Change
rsi stock-price-movement
Down -6.3% in 4 Weeks, Here's Why Smartsheet (SMAR) Looks Ripe for a Turnaround
by Zacks Equity Research
Smartsheet (SMAR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SMARPositive Net Change
rsi stock-price-movement
Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround
by Zacks Equity Research
The Oncology Institute (TOI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
TOINegative Net Change
rsi stock-price-movement
Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks
by Zacks Equity Research
Leap Therapeutics (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
LPTXPositive Net Change
rsi stock-price-movement
After Plunging -20.06% in 4 Weeks, Here's Why the Trend Might Reverse for Manchester United (MANU)
by Zacks Equity Research
Manchester United (MANU) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
MANUNegative Net Change
rsi stock-price-movement
Down -28.34% in 4 Weeks, Here's Why You Should You Buy the Dip in Matterport, Inc. (MTTR)
by Zacks Equity Research
Matterport, Inc. (MTTR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
rsi stock-price-movement
Down -9.91% in 4 Weeks, Here's Why You Should You Buy the Dip in Adobe (ADBE)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Adobe (ADBE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ADBEPositive Net Change
rsi stock-price-movement
Down -14.35% in 4 Weeks, Here's Why Galapagos NV (GLPG) Looks Ripe for a Turnaround
by Zacks Equity Research
Galapagos NV (GLPG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
GLPGNegative Net Change
rsi stock-price-movement
Down -16.81% in 4 Weeks, Here's Why You Should You Buy the Dip in Ocwen (OCN)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Ocwen (OCN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
OCNNegative Net Change
rsi stock-price-movement
Down -13.72% in 4 Weeks, Here's Why Centrus Energy Corp. (LEU) Looks Ripe for a Turnaround
by Zacks Equity Research
Centrus Energy Corp. (LEU) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
LEUNegative Net Change
rsi stock-price-movement
Cartesian Therapeutics, Inc. (RNAC) Loses -24.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Cartesian Therapeutics, Inc. (RNAC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
RNACPositive Net Change
rsi stock-price-movement
Down -24.11% in 4 Weeks, Here's Why You Should You Buy the Dip in Luminar Technologies, Inc. (LAZR)
by Zacks Equity Research
Luminar Technologies, Inc. (LAZR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
LAZRNegative Net Change
rsi stock-price-movement
McGrath (MGRC) Loses -6.12% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
McGrath (MGRC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
MGRCNegative Net Change
rsi stock-price-movement
Here's Why Montauk Renewables (MNTK) is Poised for a Turnaround After Losing -28.66% in 4 Weeks
by Zacks Equity Research
Montauk Renewables (MNTK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
MNTKNegative Net Change
rsi stock-price-movement
Down -23.56% in 4 Weeks, Here's Why Vacasa, Inc. (VCSA) Looks Ripe for a Turnaround
by Zacks Equity Research
Vacasa, Inc. (VCSA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
rsi stock-price-movement
Rekor Systems, Inc. (REKR) Loses -18.91% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Rekor Systems, Inc. (REKR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
REKRNo Net Change
rsi stock-price-movement
Here's Why Immunovant, Inc. (IMVT) is Poised for a Turnaround After Losing -8.02% in 4 Weeks
by Zacks Equity Research
The heavy selling pressure might have exhausted for Immunovant, Inc. (IMVT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
IMVTNegative Net Change
rsi stock-price-movement
Down -17.46% in 4 Weeks, Here's Why You Should You Buy the Dip in Iridium (IRDM)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Iridium (IRDM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
IRDMNegative Net Change
rsi stock-price-movement
After Plunging -23.58% in 4 Weeks, Here's Why the Trend Might Reverse for Perion Network (PERI)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Perion Network (PERI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PERINegative Net Change
rsi stock-price-movement
Dynatrace (DT) Loses -20.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Dynatrace (DT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
DTNegative Net Change
rsi stock-price-movement
Down -6.41% in 4 Weeks, Here's Why Workday (WDAY) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Workday (WDAY) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
WDAYPositive Net Change
rsi stock-price-movement